Answers are grounded in this paper and cite their sources.
TNF inhibition is being evaluated as a treatment strategy for patients with deficiency of adenosine deaminase 2, a genetic disease causing early-onset lacunar stroke.
Adenosine Deaminase 2 Deficiency and TNF Inhibition The manifestations of a deficiency of adenosine deaminase 2, a genetic disease, include early-onset lacunar stroke. In a series of 15 patients wi...
No takes yet. Share an insight, caveat, or question.
Ombrello et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: